Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

nucleotidase/asthenia

Linkul este salvat în clipboard
ArticoleStudii cliniceBrevete
13 rezultate

Positive Cytosolic 5-Nucleotidase 1A Antibodies in Motor Neuron Disease

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Inclusion body myositis (IBM) is the most common acquired myopathy in adults older than 50 years. Muscle biopsy remains the gold standard for diagnosis. Recently described serum antibodies against cytosolic 5-nucleotidase 1A (cN1A) are considered highly specific for IBM. However, positive cN1A

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE Autoantibodies directed against cytosolic 5'-nucleotidase 1A have been identified in many patients with inclusion body myositis. This retrospective study investigated the association between anticytosolic 5'-nucleotidase 1A antibody status and clinical, serological and histopathological

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Objective: Sporadic Inclusion Body Myositis (sIBM) is an inflammatory myopathy (IIM) without a specific diagnostic biomarker until autoantibodies to the cytosolic 5'-nucleotidase 1A (NT5c1A/Mup44) were reported. The objectives of our study were to determine the sensitivity and

[Sporadic Inclusion Body Myositis and Autoantibodies].

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Sporadic inclusion body myositis (sIBM) is a chronically progressing inflammatory myopathy most common in the aged population. Asymmetric muscle weakness and waste of the quadriceps and finger and wrist flexor muscles are characteristic features of sIBM. Histological findings suggest the involvement

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Introduction: Inclusion body myositis (IBM) is an idiopathic inflammatory myopathy, characterized by unique clinical features including finger flexor and quadriceps muscle weakness and a lack of any reliable treatment. The human leukocyte

Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE Autoantibodies recognising cytosolic 5'-nucleotidase 1A (NT5C1A) are found in adult patients with myositis and other autoimmune diseases. They are especially prevalent in adults with inclusion body myositis (IBM), in which they are associated with more severe weakness and higher mortality.

Abnormal liver test results in myotonic dystrophy.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Myotonic dystrophy (DM) is an autosomal dominant multisystem disorder. Little evidence suggests the existence of liver damage in a small number of patients. We have prospectively evaluated liver and gallbladder function in 53 patients with DM in relation to clinical and genetic parameters. None of

Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Merbarone, NSC 336628, is an investigational anticancer drug with activity against experimental animal tumors including melanoma. This paper presents results of a Phase II clinical study of merbarone in patients with biopsy proven stage IV malignant melanoma without prior chemotherapy and with no

Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE To characterize patients with myositis with HIV infection. METHODS All HIV-positive patients with myositis seen at the Johns Hopkins Myositis Center from 2003 to 2013 were included in this case series. Muscle biopsy features, weakness pattern, serum creatine kinase (CK) level, and

Clinical and pathological studies in cattle with hepatic disease.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
In cattle with hepatic lipidosis, hepatic abscessation, leptospirosis, biliary calculi or fasciolosis, the progression of the disease was studied by serial measurements of serum total bile acid concentrations, plasma glutamate dehydrogenase, gamma-glutamyltransferase, 5'-nucleotidase and leucine

Advances in serological diagnostics of inflammatory myopathies.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Inflammatory myopathies are rare diseases. Their diagnosis criteria are historically based on their clinical phenotype (topography of the muscle weakness, presence of skin lesions and/or of extra-skin/muscle signs) and the presence of inflammatory infiltrates on muscle biopsy. However, the recent

Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE To review new advances in inclusion body myositis (IBM) and discuss them in light of current knowledge on diagnosis, pathomechanisms, and treatment perspectives. RESULTS IBM is a treatment refractory inflammatory myopathy in middle-aged patients that leads to a slow, relentlessly

Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Inclusion body myositis is the most common acquired myopathy after the age of 50. It is characterized by progressive asymmetric weakness predominantly affecting the quadriceps and/or finger flexors. Loss of ambulation and dysphagia are major complications of the disease. Inclusion body myositis can
Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge